Metabolomics Workbench : NIH Data Repository : Analyze Studies

Data for ST004287

(Analysis AN007127): Average values per metabolite and experimental factor (Units:normalized peak area)

Metabolite structure	F1	F2	F3	F4	F5
1-O-Palmitoyl-Cer(d18:1/18:0)	-	-	-	-	-
24-Hydroxycholesterol	-	-	-	-	-
24-Hydroxycholesterol(d7)	-	-	-	-	-
3-O-SulfoLacCer(d18:1/18:0)	-	-	-	-	-
4-beta-Hydroxycholesterol	-	-	-	-	-
7-keto-Cholesterol	-	-	-	-	-
CE(16:1)	0.01	0.01	0.01	0.00	0.02
CE(18:1)	0.15	0.14	0.14	0.14	0.14
CE(18:1(d7))	-	-	-	-	-
CE(18:2)	0.01	0.01	0.01	0.00	0.01
CE(20:4)	0.03	0.06	0.04	0.03	0.01
CE(20:5)	-	-	-	-	-
CE(22:6)	0.02	0.03	0.02	0.01	0.01
CE HETE	-	-	-	-	-
CE HODE	-	-	-	-	-
CE HpODE	-	-	-	-	-
CE oxoHETE	-	-	-	-	-
CE oxoODE	-	-	-	-	-
Cer(d18:0/16:0)	-	-	-	-	-
Cer(d18:0/18:0)	-	-	-	-	-
Cer(d18:0/24:0)	-	-	-	-	-
Cer(d18:0/24:1)	-	-	-	-	-
Cer(d18:1/16:0)	0.05	0.08	0.09	0.05	0.04
Cer(d18:1/16:0(d7))	-	-	-	-	-
Cer(d18:1/18:0)	0.09	0.12	0.07	0.17	0.05
Cer(d18:1/24:0)	0.07	0.10	0.12	0.07	0.06
Cer(d18:1/24:1)	0.07	0.09	0.12	0.06	0.04
Cholesterol	0.08	0.09	0.07	0.10	0.06
Cholesterol(d7)	-	-	-	-	-
Cholesteryl hexoside	-	-	-	-	-
Coenzyme Q10	0.00	0.00	0.00	0.00	0.00
DG(15:0/18:1(d7))	-	-	-	-	-
DG(16:0_18:1)	0.15	0.16	0.14	0.13	0.15
DG(16:0_20:4)	0.01	0.01	0.01	0.01	0.01
DG(18:0_18:1)	0.10	0.10	0.09	0.09	0.10
DG(18:0_20:4)	0.02	0.02	0.01	0.03	0.01
DG(18:0_22:6)	2.60	0.04	0.04	0.05	0.05
DG(18:1/18:1)	0.09	0.09	0.10	0.10	0.11
DG(18:1_20:4)	-	-	-	-	-
GB3(d18:1/16:0)	-	-	-	-	-
GB3(d18:1/18:0)	-	-	-	-	-
GB3(d18:1/18:0(d3))	-	-	-	-	-
GB3(d18:1/24:0)	-	-	-	-	-
GB3(d18:1/24:1)	-	-	-	-	-
GlcCer(d18:1/16:0(d3))	-	-	-	-	-
GlcCer(d18:1(d5)/18:0)	-	-	-	-	-
Glucosylsphingosine(d5)	-	-	-	-	-
HexCer(d18:1/12:0)	-	-	-	-	-
HexCer(d18:1/16:0)	0.00	0.00	0.00	0.00	0.00
HexCer(d18:1/18:0)	0.02	0.03	0.01	0.04	0.01
HexCer(d18:1/22:0)	0.02	0.03	0.02	0.04	0.01
HexCer(d18:1/24:0)	0.03	0.05	0.02	0.04	0.02
HexCer(d18:1/24:1)	0.11	0.13	0.06	0.18	0.06
Hexosylsphingosine	-	-	-	-	-
LacCer(d18:1/16:0)	-	-	-	-	-
LacCer(d18:1/17:0)	-	-	-	-	-
LacCer(d18:1/18:0)	-	-	-	-	-
LacCer(d18:1/24:0)	-	-	-	-	-
LacCer(d18:1/24:1)	-	-	-	-	-
Lactosylsphingosine	-	-	-	-	-
LPC(16:0)	0.01	0.01	0.01	0.01	0.00
LPC(16:1)	-	-	-	-	-
LPC(18:0)	0.00	0.00	0.00	0.00	0.00
LPC(18:1)	0.01	0.01	0.01	0.01	0.01
LPC(18:1(d7))	-	-	-	-	-
LPC(20:4)	0.00	0.00	0.00	0.00	0.00
LPC(22:6)	0.00	0.00	0.00	0.00	0.00
LPC(24:0)	-	-	-	-	-
LPC(24:1)	-	-	-	-	-
LPC(26:0)	-	-	-	-	-
LPC(26:1)	-	-	-	-	-
lyso-GB3	-	-	-	-	-
lyso-GB3-d7	-	-	-	-	-
lyso-GB4	-	-	-	-	-
MG(16:0)	194.49	212.51	191.90	180.31	192.75
MG(16:1)	-	-	-	-	-
MG(18:0)	357.86	397.34	360.97	326.94	359.03
MG(18:1)	12.64	12.70	10.42	9.58	11.37
MG(18:1(d7))	-	-	-	-	-
MG(20:4)	-	-	-	-	-
N-Oleoylethanolamine	-	-	-	-	-
N-Palmitoyl-O-phosphocholineserine	-	-	-	-	-
Palmitoylethanolamine	-	-	-	-	-
PC(15:0/18:1(d7))	-	-	-	-	-
PC(16:0/5:0(CHO))	0.00	0.00	0.00	0.00	0.00
PC(16:0/9:0(CHO))	0.01	0.00	0.00	0.00	0.00
PC(16:0/9:0(COOH))	0.00	0.00	0.00	0.00	0.00
PC(18:0/20:4(OH[S]))	-	-	-	-	-
PC(18:0/20:4(OOH[S]))	-	-	-	-	-
PC(34:1)	0.18	0.20	0.20	0.24	0.12
PC(36:1)	0.04	0.04	0.03	0.06	0.03
PC(36:2)	0.03	0.03	0.03	0.03	0.02
PC(36:4)	0.17	0.20	0.24	0.17	0.10
PC(38:4)	0.05	0.06	0.07	0.05	0.03
PC(38:6)	0.02	0.03	0.03	0.03	0.02
PC(40:5)	0.00	0.00	0.00	0.00	0.00
PC(40:6)	0.01	0.01	0.01	0.01	0.01
PC(O-16:0/0:0)	0.00	0.00	0.00	0.00	0.00
PC(O-16:0/2:0)	0.00	0.01	0.01	0.01	0.00
PC(O-18:0/2:0)	-	-	-	-	-
PE(15:0/18:1(d7))	-	-	-	-	-
PE(18:0/20:4(OH[S]))	-	-	-	-	-
PE(18:0/20:4(OOH[S]))	-	-	-	-	-
PE(34:1)	0.09	0.10	0.09	0.13	0.07
PE(36:1)	0.13	0.15	0.14	0.22	0.11
PE(36:2)	0.10	0.09	0.09	0.13	0.07
PE(36:4)	0.10	0.10	0.13	0.09	0.06
PE(38:4)	0.58	0.62	0.65	0.61	0.35
PE(38:5)	0.15	0.13	0.14	0.13	0.09
PE(38:6)	0.33	0.30	0.24	0.47	0.19
PE(40:4)	0.05	0.06	0.04	0.09	0.03
PE(40:5)	-	-	-	-	-
PE(40:6)	0.84	0.81	0.70	1.05	0.56
PE(40:7)	0.15	0.12	0.11	0.16	0.08
Sitosteryl hexoside	-	-	-	-	-
SM(d18:1/16:0)	0.04	0.04	0.04	0.04	0.03
SM(d18:1/18:0)	0.04	0.04	0.03	0.07	0.03
SM(d18:1/24:0)	0.02	0.02	0.02	0.02	0.01
SM(d18:1/24:1)	0.02	0.03	0.02	0.02	0.01
SM(d18:1(d9)/18:1)	-	-	-	-	-
Sphinganine	-	-	-	-	-
Sphinganine 1-phosphate	-	-	-	-	-
Sphingosine	-	-	-	-	-
Sphingosine 1-phosphate	-	-	-	-	-
Sphingosine 1-phosphate-d7	-	-	-	-	-
Sphingosine 1-phosphocholine	-	-	-	-	-
Sphingosine(d17:1)	-	-	-	-	-
TG(15:0/18:1(d7)/15:0)	-	-	-	-	-
TG(18:0_36:2)	0.03	0.04	0.05	0.04	0.04
TG(18:1_34:2)	0.07	0.09	0.10	0.09	0.09
TG(18:1_34:3)	0.01	0.01	0.01	0.01	0.01
TG(20:4_32:1)	-	0.00	0.00	0.00	0.00
TG(20:4_34:2)	0.00	0.00	0.00	0.00	0.00
TG(20:4_34:3)	-	-	-	-	-
TG(20:4_36:0)	-	-	-	-	-
TG(20:4_36:2)	-	-	-	-	-
TG(20:4_36:3)	-	-	-	-	-
TG(22:6_36:2)	-	-	-	-	-
TG(22:6_38:1)	-	-	-	-	-
TG(22:6_38:2)	-	-	-	-	-

Factors:

F1	cell_line:NA \| disease_state:NA \| genotype:NA \| Sample source:microglia
F2	cell_line:PILRAKO \| disease_state:5xFAD \| genotype:5x-hCSF1 \| Sample source:microglia
F3	cell_line:PILRAKO \| disease_state:WT \| genotype:hCSF1 \| Sample source:microglia
F4	cell_line:WT \| disease_state:5xFAD \| genotype:5x-hCSF1 \| Sample source:microglia
F5	cell_line:WT \| disease_state:WT \| genotype:hCSF1 \| Sample source:microglia